Journal of Chemical Crystallography

, Volume 37, Issue 11, pp 771–777 | Cite as

X-ray Crystallographic Structures of Neuroprotective Pyrimidine Derivatives: (I) the Mesylate Salt of BW1003C87 and (II) Sipatrigine Base

  • Rex A. PalmerEmail author
  • Brian S. Potter
  • Michael J. Leach
  • Babur Z. ChowdhryEmail author
Original Paper


Drugs based on 5-phenyl-2,4 diamino pyrimidine and 6-phenyl-1,2,4 triazine derivatives are well known for their effects on the central nervous system. The study presented here provides detailed crystal structures of two pyrimidine derivatives which have neuroprotective properties in models of both grey and white matter ischemia. Recently published studies suggest that the compounds lamotrigine (a triazine derivative), and the two pyrimidines BW1003C87 (I) and sipatrigine (II) mediate their primary in vivo mode of action by inhibiting voltage-gated Na+ channels. The X-ray crystal structures will contribute valuable data for applications involving binding and modelling studies of the biological actions of these drugs.

Graphical Abstract

X-ray crystallographic structures of neuroprotective pyrimidine derivatives: (I) the mesylate salt of BW1003C87 and (II) sipatrigine base

Rex A. Palmer*, Brian S. Potter, Michael J. Leach and Babur Z. Chowdhry

Surface representations, [20] are a useful tool with respect to considerations employed for the purposes of drug design. Shown here are the neuroprotective drug molecules (a) BW1003C87 and (b) Sipatrigine Base (BW619C89) derived from their solid state structures reported in this paper. The molecules are viewed edge on to ring B with the two adjacent Cl atoms uppermost on the left.


Central nervous system drugs Pyrimidines Lamotrigines Voltage-gated Na+ channel inhibitors Crystal structures and drug design 



We thank Dr P. Barraclough (University of Greenwich) for the synthesis and provision of samples of BW1003C87 and sipatrigine.


  1. 1.
    Garthwaite G, Brown G, Batchelor AM, Goodwin DA, Garthwaite J (1999) Neuroscience 94(4):1219CrossRefGoogle Scholar
  2. 2.
    Smith SE, Meldrum BS (1995) Stroke 26:117Google Scholar
  3. 3.
    Hainsworth AH, Stefani A, Calabresi P, Smith TW, Leach MJ (2000) CNS Drug Reviews 6(2):111CrossRefGoogle Scholar
  4. 4.
    Xie XM, Garthwaite J (1996) Neuroscience 73(4):951CrossRefGoogle Scholar
  5. 5.
    Leach MJ, Marden CM, Miller AA (1986) Epilepsia 27(5):490Google Scholar
  6. 6.
    Graham SH, Chen J, Sharp FR, Simon RP (1993) J Cereb Blood Flow Metab 13(1):88Google Scholar
  7. 7.
    Yarov-Yaravoy V, McPhee JC, Idsvoog D, Pate C, Scheuer T, Catterall WA (2002) J Biol Chem 277(38):35393CrossRefGoogle Scholar
  8. 8.
    Liu G, Yarov-Yaravoy V, Nobbs M, Clair JJ, Scheuer T, Catterall WA (2003) Neuropharmacology 44(3):413CrossRefGoogle Scholar
  9. 9.
    Riddall DR, Leach MJ, Garthwaite J (2006) Mol Pharmacol 69(1):278Google Scholar
  10. 10.
    Palmer RA, Potter BS, Leach MJ, Chowdhry BZ (2007) J Org Biol Chem (Submitted)Google Scholar
  11. 11.
    Enraf-Nonius (1988) CAD-4 Software. Enraf-Nonius, HollandGoogle Scholar
  12. 12.
    Sheldrick GM (1996) SHELXL96. Program for crystal structure determination. University of Göttingen, GermanyGoogle Scholar
  13. 13.
    Sheldrick GM (1997) SHELXL97. Program for crystal structure refinement. University of Göttingen, GermanyGoogle Scholar
  14. 14.
    Farrugia LJ (1999) J Appl Cryst 32:837CrossRefGoogle Scholar
  15. 15.
    Spek AL (1990) Acta Crystallogr A46:C34Google Scholar
  16. 16.
    Barnes CL (1997) J Appl Cryst 30:568 Based on ORTEP-III (v 1.0.3) by Johnson CK, Burnett MNGoogle Scholar
  17. 17.
    Merrit EA, Bacon DJ (1997) Meth Enzymol 277:505 Implemented in WinGX (qv) and generated by Ortep-3 for WindowsGoogle Scholar
  18. 18.
    Macrae CF, Edgington PR, McCabe P, Pidcock E, Shields GP, Taylor R, Towler M, van de Streek J (2006) J Appl Cryst 39:453CrossRefGoogle Scholar
  19. 19.
    Ladd MFC, Palmer RA (2003) Structure determination by X-ray crystallography, 4th edn. Klewer-Plenum, New York, p 503Google Scholar
  20. 20.
    Humphrey W, Dalke A, Schulten K (1996) J Mol Graphics 14.1:33CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.School of Crystallography, Birkbeck CollegeUniversity of LondonLondonUK
  2. 2.School of ScienceUniversity of Greenwich (Medway Campus)KentUK

Personalised recommendations